The treatment outcome for the colorectal neuroendocrine tumor: a multi-institutional retrospective study

The treatment outcome for the colorectal neuroendocrine tumor: a multi-institutional retrospective study - The treatment outcome for the colorectal neuroendocrine tumor: a multi-institutional retrospective study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036658

Enrollment

200

Registered

2019-05-07

Start date

2018-07-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal neuroendocrine tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients who are histologically diagnosed with colorectal neuroendocrine tumor G1 and G2

Exclusion criteria

Exclusion criteria: Age <18 years the cases not treated the cases that died within 30 days after surgery the cases having the combined other malignancies the cases having incomplete clinicopathological data

Design outcomes

Primary

Measure	Time frame
The regional/distant metastasis rate and the risk factors of the colorectal neuroendocrine tumor G1 / G2 based on the 2010 WHO classification.	—

Secondary

Measure	Time frame
1.Long-term prognosis (relapse-free survival, cancer-specific survival, overall survival) of large-scale neuroendocrine tumors G1 / G2 2. The relationship between the depth of submucosal invasion and lymph node metastasis of colorectal neuroendocrine tumor G1 / G2 3. The relationship between tumor budding grade and lymph node metastasis of colorectal neuroendocrine tumor G1/G2	—

Countries

Japan

Contacts

Public Contactkeigo chida

Yokohama City University Medical Center Department of Surgery, Gastroenterological Center

o-o.ttt0123.s-k@outlook.jp+81-45-261-5656

Outcome results